| Year |
Citation |
Score |
| 2024 |
Loan Nguyen TM, Guilloux JP, Defaix C, Mendez-David I, Etting I, Alvarez JC, McGowan JC, Highland JN, Zanos P, Lovett J, Moaddel R, Corruble E, David DJ, Gould TD, Denny CA, et al. Ketamine metabolism via hepatic CYP450 isoforms contributes to its sustained antidepressant actions. Neuropharmacology. 110065. PMID 39004413 DOI: 10.1016/j.neuropharm.2024.110065 |
0.593 |
|
| 2023 |
Guilloux JP, Nguyen TML, Gardier AM. [Ketamine: a neuropsychotropic drug with an innovative mechanism of action]. Biologie Aujourd'Hui. 217: 133-144. PMID 38018940 DOI: 10.1051/jbio/2023026 |
0.598 |
|
| 2023 |
Martin H, Coursan A, Lallement J, Di Miceli M, Kandiah J, Raho I, Buttler J, Guilloux JP, De Deurwaerdere P, Layé S, Guiard BP, Magnan C, Cruciani-Guglielmacci C, Fioramonti X. Serotonergic neurons are involved in the counter-regulatory response to hypoglycemia. Journal of Neuroendocrinology. e13344. PMID 37857383 DOI: 10.1111/jne.13344 |
0.506 |
|
| 2023 |
Doan J, Defaix C, Mendez-David I, Gardier AM, Colle R, Corruble E, McGowan JC, David DJ, Guilloux JP, Tritschler L. Intrahippocampal injection of a selective blocker of NMDA receptors containing the GluN2B subunit, Ro25-6981, increases glutamate neurotransmission and induces antidepressant-like effects. Fundamental & Clinical Pharmacology. PMID 37161789 DOI: 10.1111/fcp.12917 |
0.601 |
|
| 2022 |
Lebeau RH, Mendez-David I, Kucynski-Noyau L, Henry C, Attali D, Plaze M, Colle R, Corruble E, Gardier AM, Gaillard R, Guilloux JP, David DJ. Peripheral proteomic changes after electroconvulsive seizures in a rodent model of non-response to chronic fluoxetine. Frontiers in Pharmacology. 13: 993449. PMID 36386166 DOI: 10.3389/fphar.2022.993449 |
0.647 |
|
| 2020 |
Gardier A, Nguyen TML, Defaix C, Mendez-David I, Guilloux J, Alvarez J, McGowan JC, David DJ, Denny CA. Efficacy of Intranasal Delivery of (R,S)-Ketamine to the Mouse Brain Biological Psychiatry. 87: S390-S391. DOI: 10.1016/j.biopsych.2020.02.999 |
0.549 |
|
| 2020 |
Mendez-David I, Guilloux J, Shah A, Tritschler L, Defaix C, Fossati P, Colle R, Hen R, Denny C, Gardier A, Corruble E, David D. Serotonin 3 Receptor Blockade is Involved in Vortioxetine -Induced Prevention of Anxiety/Depression Relapse Phenotype Biological Psychiatry. 87. DOI: 10.1016/J.Biopsych.2020.02.1125 |
0.792 |
|
| 2020 |
Prevot T, Li G, Knutson D, Mondal P, Mian Y, Guilloux J, Mendez-David I, David D, Cook J, Sibille E. Improved Cognitive Functions and Neurotrophic Effects of a Novel Molecule Enhancing α5-GABA-A Receptor Function in Adult or Aged Mice Biological Psychiatry. 87: S404. DOI: 10.1016/J.Biopsych.2020.02.1032 |
0.722 |
|
| 2019 |
Mendez-David I, Guilloux J, Tritschler L, Defaix C, Faye C, Colle R, Corruble E, Gardier A, Fossati P, David D. S137. Long-Term Effects of Vortioxetine (Lu AA21004) on Adult Hippocampal Neurogenesis Prevents Reinstatement of Anxiety/Depression-Like Phenotype in Mice Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.888 |
0.759 |
|
| 2019 |
Loan Nguyen TM, Defaix C, Mendez-David I, Pham TH, Guilloux J, Etting I, Alvarez J, McGowan JC, David DJ, Denny CA, Gardier A. S136. Is Ketamine Metabolism to Norketamine and (2R,6R)-HNK Necessary for its Sustained Antidepressant-Like Activity and Cortical Neurotransmitter Release in Mice? Biological Psychiatry. 85: S349. DOI: 10.1016/j.biopsych.2019.03.887 |
0.569 |
|
| 2019 |
Guilloux J, Mendez-David I, Henry C, Attali D, Plaze M, Gardier A, Gaillard R, David D. S132. Peripheral Signature of Response to Electroconvulsive Seizure in a Murine Model of Anxiety/Depression Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.883 |
0.729 |
|
| 2018 |
Tritschler L, Gaillard R, Gardier AM, David DJ, Guilloux JP. [Consequences of the monoaminergic systems cross-talk in the antidepressant activity]. L'Encephale. PMID 29801770 DOI: 10.1016/j.encep.2018.05.001 |
0.61 |
|
| 2018 |
Felice D, Guilloux JP, Pehrson A, Li Y, Mendez-David I, Gardier AM, Sanchez C, David DJ. Vortioxetine Improves Context Discrimination in Mice Through a Neurogenesis Independent Mechanism. Frontiers in Pharmacology. 9: 204. PMID 29593535 DOI: 10.3389/Fphar.2018.00204 |
0.614 |
|
| 2017 |
Tritschler L, Kheirbek MA, Dantec YL, Mendez-David I, Guilloux JP, Faye C, Doan J, Pham TH, Hen R, David DJ, Gardier AM. Optogenetic activation of granule cells in the dorsal dentate gyrus enhances dopaminergic neurotransmission in the Nucleus Accumbens. Neuroscience Research. PMID 29246683 DOI: 10.1016/j.neures.2017.12.002 |
0.623 |
|
| 2017 |
Mendez-David I, Boursier C, Domergue V, Colle R, Falissard B, Corruble E, Gardier AM, Guilloux JP, David DJ. Differential Peripheral Proteomic Biosignature of Fluoxetine Response in a Mouse Model of Anxiety/Depression. Frontiers in Cellular Neuroscience. 11: 237. PMID 28860968 DOI: 10.3389/fncel.2017.00237 |
0.667 |
|
| 2017 |
Mendez-David I, Guilloux JP, Papp M, Tritschler L, Mocaer E, Gardier AM, Bretin S, David DJ. S 47445 Produces Antidepressant- and Anxiolytic-Like Effects through Neurogenesis Dependent and Independent Mechanisms. Frontiers in Pharmacology. 8: 462. PMID 28769796 DOI: 10.3389/fphar.2017.00462 |
0.674 |
|
| 2017 |
Mekiri M, Gardier AM, David DJ, Guilloux JP. Chronic Corticosterone Administration Effects on Behavioral Emotionality in Female C57BL6 Mice. Experimental and Clinical Psychopharmacology. PMID 28287792 DOI: 10.1037/Pha0000112 |
0.767 |
|
| 2017 |
Guilloux JP, Samuels BA, Mendez-David I, Hu A, Levinstein M, Faye C, Mekiri M, Mocaer E, Gardier AM, Hen R, Sors A, David DJ. S 38093, a histamine H3 antagonist/inverse agonist, promotes hippocampal neurogenesis and improves context discrimination task in aged mice. Scientific Reports. 7: 42946. PMID 28218311 DOI: 10.1038/Srep42946 |
0.756 |
|
| 2016 |
Besson M, Guiducci S, Granon S, Guilloux JP, Guiard B, Repérant C, Faure P, Pons S, Cannazza G, Zoli M, Gardier AM, Maskos U. Alterations in alpha5* nicotinic acetylcholine receptors result in midbrain- and hippocampus-dependent behavioural and neural impairments. Psychopharmacology. 233: 3297-314. PMID 27385416 DOI: 10.1007/S00213-016-4362-2 |
0.64 |
|
| 2016 |
Darcet F, Gardier AM, Gaillard R, David DJ, Guilloux JP. Cognitive Dysfunction in Major Depressive Disorder. A Translational Review in Animal Models of the Disease. Pharmaceuticals (Basel, Switzerland). 9. PMID 26901205 DOI: 10.3390/Ph9010009 |
0.769 |
|
| 2016 |
David DJ, Tritschler L, Guilloux JP, Gardier AM, Sanchez C, Gaillard R. [Pharmacological properties of vortioxetine and its pre-clinical consequences]. L'Encephale. 42: 1S12-23. PMID 26879252 DOI: 10.1016/S0013-7006(16)30015-X |
0.64 |
|
| 2016 |
Darcet F, Gardier AM, David DJ, Guilloux JP. Chronic 5-HT4 receptor agonist treatment restores learning and memory deficits in a neuroendocrine mouse model of anxiety/depression. Neuroscience Letters. 616: 197-203. PMID 26850572 DOI: 10.1016/J.Neulet.2016.01.055 |
0.795 |
|
| 2016 |
Qesseveur G, Petit AC, Nguyen HT, Dahan L, Colle R, Rotenberg S, Seif I, Robert P, David D, Guilloux JP, Gardier AM, Verstuyft C, Becquemont L, Corruble E, Guiard BP. Genetic dysfunction of serotonin 2A receptor hampers response to antidepressant drugs: A translational approach. Neuropharmacology. 105: 142-53. PMID 26764241 DOI: 10.1016/J.Neuropharm.2015.12.022 |
0.796 |
|
| 2016 |
Siopi E, Denizet M, Gabellec MM, de Chaumont F, Olivo-Marin JC, Guilloux JP, Lledo PM, Lazarini F. Anxiety- and Depression-Like States Lead to Pronounced Olfactory Deficits and Impaired Adult Neurogenesis in Mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 518-31. PMID 26758842 DOI: 10.1523/JNEUROSCI.2817-15.2016 |
0.366 |
|
| 2015 |
Ding Y, Chang LC, Wang X, Guilloux JP, Parrish J, Oh H, French BJ, Lewis DA, Tseng GC, Sibille E. Molecular and Genetic Characterization of Depression: Overlap with other Psychiatric Disorders and Aging. Molecular Neuropsychiatry. 1: 1-12. PMID 26213687 |
0.55 |
|
| 2015 |
Colle R, Gressier F, Verstuyft C, Deflesselle E, Lépine JP, Ferreri F, Hardy P, Guilloux JP, Petit AC, Fève B, Falissard B, Becquemont L, Corruble E. Brain-derived neurotrophic factor Val66Met polymorphism and 6-month antidepressant remission in depressed Caucasian patients. Journal of Affective Disorders. 175: 233-40. PMID 25658497 DOI: 10.1016/j.jad.2015.01.013 |
0.394 |
|
| 2015 |
Guilloux JP, Bassi S, Ding Y, Walsh C, Turecki G, Tseng G, Cyranowski JM, Sibille E. Testing the predictive value of peripheral gene expression for nonremission following citalopram treatment for major depression. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 701-10. PMID 25176167 DOI: 10.1038/Npp.2014.226 |
0.597 |
|
| 2015 |
Mendez-David I, David DJ, Guilloux JP, Hen R, Gardier AM. 5-ht4 receptor subtype, β-arrestin level, and rapid-onset effects of antidepressant drugs Neuromethods. 95: 101-121. DOI: 10.1007/978-1-4939-2187-4_6 |
0.65 |
|
| 2014 |
Tritschler L, Felice D, Colle R, Guilloux JP, Corruble E, Gardier AM, David DJ. Vortioxetine for the treatment of major depressive disorder. Expert Review of Clinical Pharmacology. 7: 731-45. PMID 25166025 DOI: 10.1586/17512433.2014.950655 |
0.682 |
|
| 2014 |
Le Dantec Y, Hache G, Guilloux JP, Guiard BP, David DJ, Adrien J, Escourrou P. NREM sleep hypersomnia and reduced sleep/wake continuity in a neuroendocrine mouse model of anxiety/depression based on chronic corticosterone administration. Neuroscience. 274: 357-68. PMID 24909899 DOI: 10.1016/J.Neuroscience.2014.05.050 |
0.479 |
|
| 2014 |
Darcet F, Mendez-David I, Tritschler L, Gardier AM, Guilloux JP, David DJ. Learning and memory impairments in a neuroendocrine mouse model of anxiety/depression. Frontiers in Behavioral Neuroscience. 8: 136. PMID 24822041 DOI: 10.3389/Fnbeh.2014.00136 |
0.789 |
|
| 2013 |
Guilloux JP, Mendez-David I, Pehrson A, Guiard BP, Repérant C, Orvoën S, Gardier AM, Hen R, Ebert B, Miller S, Sanchez C, David DJ. Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice. Neuropharmacology. 73: 147-59. PMID 23721744 DOI: 10.1016/J.Neuropharm.2013.05.014 |
0.767 |
|
| 2013 |
Douillard-Guilloux G, Guilloux JP, Lewis DA, Sibille E. Anticipated brain molecular aging in major depression. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 21: 450-60. PMID 23570888 DOI: 10.1016/J.Jagp.2013.01.040 |
0.564 |
|
| 2012 |
Tripp A, Oh H, Guilloux JP, Martinowich K, Lewis DA, Sibille E. Brain-derived neurotrophic factor signaling and subgenual anterior cingulate cortex dysfunction in major depressive disorder. The American Journal of Psychiatry. 169: 1194-202. PMID 23128924 DOI: 10.1176/Appi.Ajp.2012.12020248 |
0.583 |
|
| 2012 |
Xia L, Deloménie C, David I, Rainer Q, Marouard M, Delacroix H, David DJ, Gardier AM, Guilloux JP. Ventral hippocampal molecular pathways and impaired neurogenesis associated with 5-HT₁A and 5-HT₁B receptors disruption in mice. Neuroscience Letters. 521: 20-5. PMID 22622174 DOI: 10.1016/J.Neulet.2012.05.046 |
0.733 |
|
| 2012 |
Guilloux JP, Douillard-Guilloux G, Kota R, Wang X, Gardier AM, Martinowich K, Tseng GC, Lewis DA, Sibille E. Molecular evidence for BDNF- and GABA-related dysfunctions in the amygdala of female subjects with major depression. Molecular Psychiatry. 17: 1130-42. PMID 21912391 DOI: 10.1038/Mp.2011.113 |
0.723 |
|
| 2012 |
Besson M, David V, Baudonnat M, Cazala P, Guilloux JP, Reperant C, Cloez-Tayarani I, Changeux JP, Gardier AM, Granon S. Alpha7-nicotinic receptors modulate nicotine-induced reinforcement and extracellular dopamine outflow in the mesolimbic system in mice. Psychopharmacology. 220: 1-14. PMID 21901321 DOI: 10.1007/S00213-011-2422-1 |
0.565 |
|
| 2012 |
Rainer Q, Xia L, Guilloux JP, Gabriel C, Mocaër E, Hen R, Enhamre E, Gardier AM, David DJ. Beneficial behavioural and neurogenic effects of agomelatine in a model of depression/anxiety. The International Journal of Neuropsychopharmacology. 15: 321-35. PMID 21473810 DOI: 10.1017/S1461145711000356 |
0.793 |
|
| 2011 |
Guilloux JP, David DJ, Xia L, Nguyen HT, Rainer Q, Guiard BP, Repérant C, Deltheil T, Toth M, Hen R, Gardier AM. Characterization of 5-HT(1A/1B)-/- mice: an animal model sensitive to anxiolytic treatments. Neuropharmacology. 61: 478-88. PMID 21333660 DOI: 10.1016/J.Neuropharm.2011.02.009 |
0.787 |
|
| 2011 |
Guilloux JP, Seney M, Edgar N, Sibille E. Integrated behavioral z-scoring increases the sensitivity and reliability of behavioral phenotyping in mice: relevance to emotionality and sex. Journal of Neuroscience Methods. 197: 21-31. PMID 21277897 DOI: 10.1016/J.Jneumeth.2011.01.019 |
0.791 |
|
| 2010 |
Gaiteri C, Guilloux JP, Lewis DA, Sibille E. Altered gene synchrony suggests a combined hormone-mediated dysregulated state in major depression. Plos One. 5: e9970. PMID 20376317 DOI: 10.1371/Journal.Pone.0009970 |
0.738 |
|
| 2010 |
Guilloux JP, Gaiteri C, Sibille E. Network analysis of positional candidate genes of schizophrenia highlights...more than... myelin-related pathways. Molecular Psychiatry. 15: 786-8. PMID 20351722 DOI: 10.1038/mp.2009.68 |
0.653 |
|
| 2010 |
Cazorla M, Jouvenceau A, Rose C, Guilloux JP, Pilon C, Dranovsky A, Prémont J. Cyclotraxin-B, the first highly potent and selective TrkB inhibitor, has anxiolytic properties in mice. Plos One. 5: e9777. PMID 20333308 DOI: 10.1371/Journal.Pone.0009777 |
0.381 |
|
| 2010 |
Popa D, Cerdan J, Repérant C, Guiard BP, Guilloux JP, David DJ, Gardier AM. A longitudinal study of 5-HT outflow during chronic fluoxetine treatment using a new technique of chronic microdialysis in a highly emotional mouse strain. European Journal of Pharmacology. 628: 83-90. PMID 19944680 DOI: 10.1016/j.ejphar.2009.11.037 |
0.73 |
|
| 2010 |
Rainer Q, Gabriel C, Mocaer E, Xia L, Hen R, Enhamre E, Guilloux J, Gardier A, David D. P01-74 - Beneficial effects of chronic treatment with agomelatine on the anxiety-and depression-like state induced by corticosterone in C57BL/6NTAC mice European Psychiatry. 25: 295. DOI: 10.1016/S0924-9338(10)70293-5 |
0.799 |
|
| 2009 |
David DJ, Samuels BA, Rainer Q, Wang JW, Marsteller D, Mendez I, Drew M, Craig DA, Guiard BP, Guilloux JP, Artymyshyn RP, Gardier AM, Gerald C, Antonijevic IA, Leonardo ED, et al. Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron. 62: 479-93. PMID 19477151 DOI: 10.1016/J.Neuron.2009.04.017 |
0.776 |
|
| 2009 |
Gardier AM, Guiard BP, Guilloux JP, Repérant C, Coudoré F, David DJ. Interest of using genetically manipulated mice as models of depression to evaluate antidepressant drugs activity: a review. Fundamental & Clinical Pharmacology. 23: 23-42. PMID 19267769 DOI: 10.1111/j.1472-8206.2008.00640.x |
0.76 |
|
| 2008 |
Deltheil T, Guiard BP, Cerdan J, David DJ, Tanaka KF, Repérant C, Guilloux JP, Coudoré F, Hen R, Gardier AM. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice. Neuropharmacology. 55: 1006-14. PMID 18761360 DOI: 10.1016/j.neuropharm.2008.08.001 |
0.773 |
|
| 2008 |
Deltheil T, Guiard BP, Guilloux JP, Nicolas L, Deloménie C, Repérant C, Le Maitre E, Leroux-Nicollet I, Benmansour S, Coudoré F, David DJ, Gardier AM. Consequences of changes in BDNF levels on serotonin neurotransmission, 5-HT transporter expression and function: studies in adult mice hippocampus. Pharmacology, Biochemistry, and Behavior. 90: 174-83. PMID 17980409 DOI: 10.1016/j.pbb.2007.09.018 |
0.71 |
|
| 2007 |
Guiard BP, Guilloux JP, Reperant C, Hunt SP, Toth M, Gardier AM. Substance P neurokinin 1 receptor activation within the dorsal raphe nucleus controls serotonin release in the mouse frontal cortex. Molecular Pharmacology. 72: 1411-8. PMID 17890358 DOI: 10.1124/mol.107.040113 |
0.736 |
|
| 2006 |
Molles BE, Maskos U, Pons S, Besson M, Guiard P, Guilloux JP, Evrard A, Cormier A, Mameli-Engvall M, Cloëz-Tayarani I, Nakatani H, Dufour N, Bemelmans AP, Mallet J, Cazala P, et al. Targeted in vivo expression of nicotinic acetylcholine receptors in mouse brain using lentiviral expression vectors. Journal of Molecular Neuroscience : Mn. 30: 105-6. PMID 17192649 DOI: 10.1385/JMN:30:1:105 |
0.543 |
|
| 2006 |
Guilloux JP, David DJ, Guiard BP, Chenu F, Repérant C, Toth M, Bourin M, Gardier AM. Blockade of 5-HT1A receptors by (+/-)-pindolol potentiates cortical 5-HT outflow, but not antidepressant-like activity of paroxetine: microdialysis and behavioral approaches in 5-HT1A receptor knockout mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 2162-72. PMID 16452992 DOI: 10.1038/sj.npp.1301019 |
0.749 |
|
| 2005 |
Maskos U, Molles BE, Pons S, Besson M, Guiard BP, Guilloux JP, Evrard A, Cazala P, Cormier A, Mameli-Engvall M, Dufour N, Cloëz-Tayarani I, Bemelmans AP, Mallet J, Gardier AM, et al. Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature. 436: 103-7. PMID 16001069 DOI: 10.1038/Nature03694 |
0.663 |
|
| 2004 |
Bert L, Favale D, Jego G, Greve P, Guilloux JP, Guiard BP, Gardier AM, Suaud-Chagny MF, Lestage P. Rapid and precise method to locate microdialysis probe implantation in the rodent brain. Journal of Neuroscience Methods. 140: 53-7. PMID 15589334 DOI: 10.1016/j.jneumeth.2004.04.042 |
0.626 |
|
| 2004 |
Guiard BP, Przybylski C, Guilloux JP, Seif I, Froger N, De Felipe C, Hunt SP, Lanfumey L, Gardier AM. Blockade of substance P (neurokinin 1) receptors enhances extracellular serotonin when combined with a selective serotonin reuptake inhibitor: an in vivo microdialysis study in mice. Journal of Neurochemistry. 89: 54-63. PMID 15030389 DOI: 10.1046/j.1471-4159.2003.02304.x |
0.72 |
|
| Show low-probability matches. |
